Previous Close | 15.12 |
Open | 15.15 |
Bid | 12.50 x 1100 |
Ask | 12.63 x 1300 |
Day's Range | 14.75 - 15.63 |
52 Week Range | 11.83 - 27.65 |
Volume | |
Avg. Volume | 3,396,591 |
Market Cap | 4.735B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.02 |
Earnings Date | Jun 05, 2024 - Jun 10, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Mar 14, 2019 |
1y Target Est | 5.88 |
Subscribe to Yahoo Finance Plus to view Fair Value for GME
GameStop (GME) shares dive in extended-hours hours after missing fourth-quarter earnings estimates, falling short of both revenue — posting $1.79 billion versus an expected $2.05 billion — and adjusted EPS — $0.22 per share versus expected gains of $0.30 per share — forecasts. Yahoo Finance Live breaks down GameStop shares' journey since the meme stock frenzy of early 2021. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Luke Carberry Mogan.
GameStop’s fiscal fourth-quarter revenue misses analysts’ estimates, Trump Media surges for a second day, and Merck’s treatment for pulmonary arterial hypertension receives FDA approval.Read the full ...
GameStop’s fiscal fourth-quarter revenue misses analysts’ estimates, Trump Media surges for a second day, and Merck’s treatment for pulmonary arterial hypertension receives FDA approval.